These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21478494)

  • 1. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk.
    Nan H; Xu M; Zhang J; Zhang M; Kraft P; Qureshi AA; Chen C; Guo Q; Hu FB; Rimm EB; Curhan G; Song Y; Amos CI; Wang LE; Lee JE; Wei Q; Hunter DJ; Han J
    Hum Mol Genet; 2011 Jul; 20(13):2673-9. PubMed ID: 21478494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.
    Ransohoff KJ; Wu W; Cho HG; Chahal HC; Lin Y; Dai HJ; Amos CI; Lee JE; Tang JY; Hinds DA; Han J; Wei Q; Sarin KY
    Oncotarget; 2017 Mar; 8(11):17586-17592. PubMed ID: 28212542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
    Falchi M; Bataille V; Hayward NK; Duffy DL; Bishop JA; Pastinen T; Cervino A; Zhao ZZ; Deloukas P; Soranzo N; Elder DE; Barrett JH; Martin NG; Bishop DT; Montgomery GW; Spector TD
    Nat Genet; 2009 Aug; 41(8):915-9. PubMed ID: 19578365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Nevus Count Exhibits a Distinct DNA Methylation Signature in Healthy Human Skin: Implications for Melanoma.
    Roos L; Sandling JK; Bell CG; Glass D; Mangino M; Spector TD; Deloukas P; Bataille V; Bell JT
    J Invest Dermatol; 2017 Apr; 137(4):910-920. PubMed ID: 27993549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.
    Landi MT; Bishop DT; MacGregor S; Machiela MJ; Stratigos AJ; Ghiorzo P; Brossard M; Calista D; Choi J; Fargnoli MC; Zhang T; Rodolfo M; Trower AJ; Menin C; Martinez J; Hadjisavvas A; Song L; Stefanaki I; Scolyer R; Yang R; Goldstein AM; Potrony M; Kypreou KP; Pastorino L; Queirolo P; Pellegrini C; Cattaneo L; Zawistowski M; Gimenez-Xavier P; Rodriguez A; Elefanti L; Manoukian S; Rivoltini L; Smith BH; Loizidou MA; Del Regno L; Massi D; Mandala M; Khosrotehrani K; Akslen LA; Amos CI; Andresen PA; Avril MF; Azizi E; Soyer HP; Bataille V; Dalmasso B; Bowdler LM; Burdon KP; Chen WV; Codd V; Craig JE; Dębniak T; Falchi M; Fang S; Friedman E; Simi S; Galan P; Garcia-Casado Z; Gillanders EM; Gordon S; Green A; Gruis NA; Hansson J; Harland M; Harris J; Helsing P; Henders A; Hočevar M; Höiom V; Hunter D; Ingvar C; Kumar R; Lang J; Lathrop GM; Lee JE; Li X; Lubiński J; Mackie RM; Malt M; Malvehy J; McAloney K; Mohamdi H; Molven A; Moses EK; Neale RE; Novaković S; Nyholt DR; Olsson H; Orr N; Fritsche LG; Puig-Butille JA; Qureshi AA; Radford-Smith GL; Randerson-Moor J; Requena C; Rowe C; Samani NJ; Sanna M; Schadendorf D; Schulze HJ; Simms LA; Smithers M; Song F; Swerdlow AJ; van der Stoep N; Kukutsch NA; Visconti A; Wallace L; Ward SV; Wheeler L; Sturm RA; Hutchinson A; Jones K; Malasky M; Vogt A; Zhou W; Pooley KA; Elder DE; Han J; Hicks B; Hayward NK; Kanetsky PA; Brummett C; Montgomery GW; Olsen CM; Hayward C; Dunning AM; Martin NG; Evangelou E; Mann GJ; Long G; Pharoah PDP; Easton DF; Barrett JH; Cust AE; Abecasis G; Duffy DL; Whiteman DC; Gogas H; De Nicolo A; Tucker MA; Newton-Bishop JA; ; ; ; ; ; ; ; ; ; Peris K; Chanock SJ; Demenais F; Brown KM; Puig S; Nagore E; Shi J; Iles MM; Law MH
    Nat Genet; 2020 May; 52(5):494-504. PubMed ID: 32341527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
    Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
    J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
    Duffy DL; Zhu G; Li X; Sanna M; Iles MM; Jacobs LC; Evans DM; Yazar S; Beesley J; Law MH; Kraft P; Visconti A; Taylor JC; Liu F; Wright MJ; Henders AK; Bowdler L; Glass D; Ikram MA; Uitterlinden AG; Madden PA; Heath AC; Nelson EC; Green AC; Chanock S; Barrett JH; Brown MA; Hayward NK; MacGregor S; Sturm RA; Hewitt AW; ; Kayser M; Hunter DJ; Newton Bishop JA; Spector TD; Montgomery GW; Mackey DA; Smith GD; Nijsten TE; Bishop DT; Bataille V; Falchi M; Han J; Martin NG
    Nat Commun; 2018 Nov; 9(1):4774. PubMed ID: 30429480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
    Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
    Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype.
    Bertram CG; Gaut RM; Barrett JH; Randerson-Moor J; Whitaker L; Turner F; Bataille V; dos Santos Silva I; Swerdlow AJ; Bishop DT; Newton Bishop JA
    J Invest Dermatol; 2004 Feb; 122(2):429-32. PubMed ID: 15009726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants at the 9p21 locus and melanoma risk.
    Maccioni L; Rachakonda PS; Bermejo JL; Planelles D; Requena C; Hemminki K; Nagore E; Kumar R
    BMC Cancer; 2013 Jul; 13():325. PubMed ID: 23816148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
    Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
    Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes Determining Nevus Count and Dermoscopic Appearance in Australian Melanoma Cases and Controls.
    Duffy DL; Jagirdar K; Lee KJ; McWhirter SR; McMeniman EK; De'Ambrosis B; Pflugfelder A; Rayner JE; Whiteman DC; Brown MA; Martin NG; Smithers BM; Schaider H; Soyer HP; Sturm RA
    J Invest Dermatol; 2020 Feb; 140(2):498-501.e17. PubMed ID: 31421127
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.
    Liu H; Wang LE; Liu Z; Chen WV; Amos CI; Lee JE; ; ; Iles MM; Law MH; Barrett JH; Montgomery GW; Taylor JC; MacGregor S; Cust AE; Newton Bishop JA; Hayward NK; Bishop DT; Mann GJ; Affleck P; Wei Q
    Carcinogenesis; 2013 Apr; 34(4):885-92. PubMed ID: 23291271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
    Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
    Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
    Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
    Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
    Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Genomic Profiling of Melanocytic Nevi.
    Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
    J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.
    Carli P; Massi D; Santucci M; Biggeri A; Giannotti B
    J Am Acad Dermatol; 1999 Apr; 40(4):549-57. PubMed ID: 10188672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
    Bishop JA; Wachsmuth RC; Harland M; Bataille V; Pinney E; MacK P; Baglietto L; Cuzick J; Bishop DT
    J Invest Dermatol; 2000 Jan; 114(1):28-33. PubMed ID: 10620111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.